Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/ CFS)

Condition: Chronic fatigue syndrome

Category: Rheumatology

Type: Article

Author: Olli Polo

Date: Nov 2019

A report on the safety and effectiveness data accumulated in clinical practice when treating ME/CFS with low dose naltrexone. The high frequency of treatment response and good safety profile observed could prompt prospective controlled studies to confirm the feasibility of LDN in alleviating ME/CFS symptoms.

Not Finding What You're Looking For?

Fill out the form below to let us know.